Purpose To report macular ischaemia and visual loss in patients with panuveitis due to Beh.;; et's disease. 
Beh<;:et's disease is a chronic multisystem disorder characterised by a generalised vasculitis of unknown aetiology. In 1990, the International Study Group for Beh<;:et's Disease (ISGBD) proposed a standardised set of diagnostic criteria. 1 These include recurrent oral ulceration and two of the following findings: characteristic eye lesions, recurrent genital ulceration, characteristic skin lesions, or a positive pathergy test. The ocular manifestations of Beh<;:et's disease include non granulomatous iridocyclitis, occlusive retinal vasculitis involving both arteries and veins, inflammatory response of the vitreous, retinal haemorrhages, infiltrates and oedema? The posterior segment involvement leads to irreversible alterations and serious visual loss. Although macular alterations, such as macular oedema, macular hole, epiretinal membrane formation and subretinal neovascularisation3 secondary to Beh<;:et's disease and other uveitis have been reported, macular ischaemia 4, 5 has been noted in just a few reports. In this report GURSEL YILMAZ, YONCA AKOVA,
PINAR AYDIN
we discuss the findings on fundus fluorescein angiography (FFA) of the presence of macular ischaemia in 3 eyes of 3 patients with active panuveitis and Beh<;:et's disease.
Case reports

Case 1
A 30-year-old man was referred to us for blurred vision, redness and pain in the right eye and mild visual loss in the left eye. On initial examination, best corrected visual acuity was counting fingers at 3 m in the right eye, 20/20 in the left eye. Slit-lamp examination revealed 2+ cells in the anterior chamber and 3+ cells in the vitreous in the right eye, and 1 + cells in the anterior chamber and 1 + cells in the vitreous in the left eye. Fundus examination showed cystoid macular oedema, retinal vasculitis and retinal haemorrhages in the right eye, and mild cystoid macular oedema in the left eye. FFA showed leakage from the optic disc, irregularity of the foveal avascular zone and perifoveal capillary drop-out with microvascular abnormalities (Fig. 1a,b) , and retinal vasculitis in the right eye. Hyperfluorescence of the optic disc and cystoid macular oedema were seen in the left eye. Beh<;:et's disease was diagnosed based on the ISGBD criteria since our patient had a history of erythema-nodosum-like eruptions, recurrent oral aphthous ulcerations, genital ulceration and arthritis. In addition, HLA typing showed that the HLA B51 antigen was present and a pathergy test was positive.
Topical, transseptal and systemic corticosteroids as well as oral cyclosporin A (300 mg/ day) treatment was initiated. With this therapy, the inflammation was controlled with resolution of vitreous inflammation and retinal infiltrates. Visual acuity improved to 20/200 within 3 weeks and we observed that macular ischaemia partially resolved on FFA (Fig. 1c) . Both the visual acuity and macula remained stable during the 2 year follow-up period under treatment.
Case 2
A 19-year-old man presented complaining of blurred vision, redness and pain in both eyes, with the left eye worse than the right. The patient reporting having had blurring of vision for the previous 4 months in both eyes. He had a irregularity of the foveal avascular zone in the left eye (Fig. 3a) . Systemic signs included oral ulceration, genital ulcers, erythema nodosum and arthritis.
The diagnosis of Beh<;et's disease was confirmed and azathioprine (150 mg/ day) was added to the treatment regime with systemic steroids. Visual acuity did not improve and macular ischaemia did not resolve on FFA (Fig. 3b) . Six months later, cataract surgery was performed on the left eye without any complication.
Although inflammation was under control, neither the macular ischaemia nor the visual acuity improved during the 2 year follow-up period. Retinal involvement is the most disquieting aspect of Beh«;et's disease and can ultimately lead to severe visual 10SS. 10 , 11 We consider active panuveitis as the treatment guideline in our patients. However, when we achieved control of the inflammation, the macular ischaemia also improved in 2 of 3 patients. Little attention has been paid to macular ischaemia in the past; it is a rare finding in Beh«;et's disease and there are no established criteria concerning its treatment in these patients. However, in our experiences described above, when inflammation is brought under control, macular ischaemia may also improve. Every effort should be made to control ocular inflammation in Beh«;et's disease.
